Table 1.
Classification | Test | Result | Data |
---|---|---|---|
Morphology | Photography | Normal hiPSC morphology | Fig. 1 Panel C |
Phenotype | Qualitative analysis | Immunohistochemistry of pluripotency markers: Oct4A, Nanog, Sox2, TRA-1-60, TRA-1-81 | Fig. 1 Panel E |
Quantitative analysis | Expression of pluripotency marker Oct4 by flow cytometry | Fig. 1 Panel D | |
Genotype | Karyotype (G-banding) and resolution | Normal Karyotype: 46,XY, resolution: 480 band level | Fig. 1 Panel G |
Identity | STR analysis | 17 loci tested, 100% match | Submitted in archive with journal |
Mutation analysis (IF | PCR and sequencing | Heterozygous targeted integration | Fig. 1 Panel F |
APPLICABLE) | Southern Blot OR WGS | Not performed. Top 10 predicted coding and non-coding off-targets were sequenced, detecting no indel formation. | Available by request |
Microbiology and virology | Mycoplasma | Mycoplasma testing by PCR: Negative | Supplementary Fig. 4 |
Differentiation potential | Embryoid body formation and Directed neural differentiation | Expression of genes from three germ layers following spontaneous differentiation: AFP, TBXT, MSI1 Directed neural differentiation immunohistochemistry: Human Nestin, Medium-length neurofilament polypeptide |
Fig. 1 Panel H and I |
Donor screening (OPTIONAL) | HIV 1 + 2 Hepatitis B, Hepatitis C | Not performed | N/A |
Genotype additional info | Blood group genotyping | Not performed | N/A |
(OPTIONAL) | HLA tissue typing | Not performed | N/A |